Skip to content

Empathy & psychosis

Empathy & psychosis - Empathy & psychosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44395
Enrollment
90
Registered
2015-03-30
Start date
2016-11-24
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychosis

Interventions

None listed

Sponsors

Rijksuniversiteit Groningen
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with schizophrenia:;- Diagnosis of schizophrenia or schizoaffective disorder, according to DSM-IV-TR criteria; - Being able to give informed consent; - 18 years or older; - No change in medication in the past thirty days; - Low metacognition (group 1) and high metacognition (group 2). ;Patients in UHR group:;- At risk of psychosis determined by genetic risk or the CAARMS; - Being able to give informed consent; - No change in medication in the past thirty days.

Exclusion criteria

Exclusion criteria: All participants:;- Florid psychosis; - Comorbid neurological disorder; - Substance dependence (not substance abuse); - IQ

Design outcomes

Primary

MeasureTime frame
Empathy as measured with the Empathic Accuracy Test, Faux Pas Test, Interpersonal Reactivity Index, Questionnaire of Cognitive and Affective Empathy en the Metacognition Assessment Scale.

Secondary

MeasureTime frame
Social functioning (Time Use) Insight (Beck Cognitive Insight Scale), Depression (Quick Inventory of Depressve Symptomalogy), Stigma (Internalized Stigma of Mental Illness Scale) Quality of Life (Manchester Short Assessment of Quality of Life).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)